No Detail Found!

Association of HLA-B51/5 in Patients of Behcet s Disease Referred to a Tertiary Care Hospital in Pakistan

Author(s)
Mustajab Alam Department of Immunology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Usama Bin Khalid Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Dawood Ahmad Department of Immunology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Muhammad Omair Riaz Department of Immunology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Muhammad Hussain Department of Immunology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Muhammad Zain Arshad Department of Immunology, Armed Forces Institute of Pathology,Rawalpindi,Pakistan
Abstract
Objective: To determine the association of HLA-B51/5 in patients of Behcet s disease (BD) in local symptomatic patients. Study Design: A cross-sectional study. Place and Duration of the Study: Department of Immunology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from August 2020 to July 2023. Methodology: Blood samples of 100 study participants, including 50 symptomatic patients of BD and 50 disease-free individuals (healthy controls), were taken. DNA was extracted and ampli ed using sequence-speci c primers. Electrophoresis was conducted on 2% agarose gel to separate the DNA. The presence of HLA-B51/5 alleles was determined by analysing the unique band patterns visible on the gel under the ultraviolet light. Descriptive statistics were shown as mean ± SD. Chi-square test was employed to nd any signi cant association between HLA-B51/5 and the disease group and its severity sub-groups. A p-value of less than 0.05 was deemed signi cant. Results: The majority of participants, 73 (73%), were females and 27 (27%) were males, with a mean age of 26.84 ± 5.31 years. HLAB51/5 was positive in 33 of the BD patients (66.0%, <0.001) and 4 of the healthy controls (8.0%). There was no signi cant di erence in HLA-B51 among mild, moderate, and severe BD sub-groups. Conclusion: HLA-B51/5 is strongly associated with BD in local population and serves as a useful tool for diagnosis of BD. However, it is not associated with the disease severity.
Publication Details
Page(s) 247-250
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Electrophoresis, HLA-B51/5 allele, ICBD criteria, Agarose gel, Behcet s disease
References
.0000000000002023 .. J Clin Rheumatol, 10(7) : 341-6.
Ostrovsky M,Rosenblatt A,Iriqat S,Shteiwi A,Sharon Y,Kramer M .2023 .Ocular behcet disease-clinical manifestations, treatments and outcomes according to age at disease onset. Biomedicines, 10(2) : 624.
AboAloioun ZI,Mostafa NM,Ismael EO,Kamal D. .2022 .Clinical manifestations in Behcet s diseased patients: Is it a ected by disease activity?. Egyp J Hosp Med, 260748(1) : 4833-8.
Gul A,Wallace GR,Yazici Y,Hatemi G,Seyahi E,Yazici H .2020 .Genetics of Behcet s disease. , 10 : 16.
Alibaz-Oner F,Direskeneli H. .2021 .Advances in the treatment of Behcet s disease. Curr Rheumatol Rep, 10(6) : 47.
Davatchi F,Jamshidi AR,Banihashemi AT,Gholami J,Forouzanfar MH,Akhlaghi M .2008 .WHO-ILAR COPCORD study (stage 1, urban study. Iran.J Rheumatol, 35(7) : 1384.
Carrio JR,Nucera V,Masala IF,Atzeni F .2021 .Behcet disease: From pathogenesis to novel therapeutic options. Pharmacol Res, 105593 : 105593.
Demirkesen C,Oz B,Goksel S.,Yazici Y,Hatemi G,Seyahi E,Yazici H .2020 .Behcet syndrome: Pathology. , 10 : 12.
Davatchi F,Chams Davatchi C,Shams H,Nadji A,Faezi T,Akhlaghi M .2016 .. Adult Behcet s disease in Iran: Analysis of 6075 patients. Int J Rheum Dis, 10(1) : 12691-185X.
Sakly N,Boumiza R,Hassen SZ,Hamzaoui A,Yahia SB,Amara H .2009 .HLA B27 and HLA B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behcet s disease. Ann NY Acad Sci, 04756(1) : 6632-9.
Nishiyama M,Nakae K,Umehara T. .2001 .A study of familial occurrence of Behcet s disease with and without ocular lesions. Jpn J Ophthalmol, 5155(01) : 00321-5.
Maldini C,LaValley MP,Cheminant M,de Menthon M,Mahr A .2012 .Relationships of HLA-B51 or B5 genotype with Behcet s disease clinical characteristics: Systematic review and meta-analyses of observational studies. Rheumatology, 10(5) : 887-900.
0

Citations

0

Downloads

171

Views